Michael T Wijas Net Worth

The estimated Net Worth of Michael T Wijas is at least 311 千$ dollars as of 1 June 2017. Michael Wijas owns over 2,346 units of Lemaitre Vascular Inc stock worth over 310,912$ and over the last 9 years Michael sold LMAT stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michael Wijas LMAT stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Lemaitre Vascular Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Michael exercised 2,346 units of LMAT stock worth 29,935$ on 1 June 2017.

The largest trade Michael's ever made was exercising 2,346 units of Lemaitre Vascular Inc stock on 1 June 2017 worth over 29,935$. On average, Michael trades about 261 units every 0 days since 2015. As of 1 June 2017 Michael still owns at least 3,584 units of Lemaitre Vascular Inc stock.

You can see the complete history of Michael Wijas stock trades at the bottom of the page.

What's Michael Wijas's mailing address?

Michael's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.

Insiders trading at Lemaitre Vascular Inc

Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over 169,251,022$ worth of Lemaitre Vascular Inc stock and bought 22,755 units worth 292,783$ . The most active insiders traders include George W Le Maitre、Guido J Neels、David B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of 1,488,890$. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth 107,236$.

What does Lemaitre Vascular Inc do?

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

Complete history of Michael Wijas stock trades at Lemaitre Vascular Inc

Lemaitre Vascular Inc executives and stock owners

Lemaitre Vascular Inc executives and other stock owners filed with the SEC include:

• George LeMaitre,
  Chairman of the Board, Chief Executive Officer
• David Roberts,
  President, Director
• Joseph Pellegrino,
  Chief Financial Officer, Director
• George W. LeMaitre,
  Chairman & CEO
• Trent Kamke,
  Senior Vice President - Operations
• David B. Roberts,
  Pres & Director
• Joseph P. Pellegrino Jr.,
  CFO, Treasurer, Sec. & Director
• Trent G. Kamke,
  Sr. VP of Operations
• John O'Connor,
  Independent Director
• Lawrence Jasinski,
  Independent Director
• John Roush,
  Independent Director
• Bridget Ross,
  Independent Director
• James Russell,
  Director, Operations
• Helen Goulding,
  Director, Sales - Northern Europe
• Ryan Connelly,
  Vice President - Research & Development
• Xiang Zhang,
  Vice President, Regulatory Affairs
• Jacob Petersen,
  Vice President, Asia-Pac
• Jonathan Ngau,
  Vice President - Information Technology
• Roli Kumar-Choudhury,
  Vice President, Quality Affairs
• Kimberly Cieslak,
  Vice President - Marketing
• Chance Kriesel,
  Vice President - Sales, The Americas
• Giovannella Deiure,
  Vice President, Sales – Southern Europe
• Stephane Maier,
  Vice President, EMEA Operations
• Andrew Hodgkinson,
  Senior Vice President - Clinical, Regulatory and Quality Affairs
• Laurie Churchill,
  Senior Vice President, General Counsel
• Stephane Maier,
  Sr. VP of EMEA Operations
• Andrew Hodgkinson,
  Sr. VP of Clinical, Regulatory & Quality Affairs
• Daniel J. Mumford,
  Director of HR
• Kimberly L. Cieslak,
  VP of Marketing
• Laurie A. Churchill,
  Sr. VP & Gen. Counsel
• Dr. George D. LeMaitre,
  Founder and Chairman of Scientific Advisory Board
• Cornelia W Le Maitre,
  V.P., Human Resources,Director
• Michael T Wijas,
  VP of Sales, The Americas
• Michael H Thomas,
  Director
• Russell D Hays,
  Director
• Aaron M Grossman,
  General Counsel
• William N Jr Thorndike,
  Director
• Equity Investors Lp/Ma Hous...,
  
• George D Le Maitre,
  Director
• Michael C Jackson,
  Director
• Robert V Linden,
  VP, North American Sales
• Peter R Gebauer,
  President, International OP
• Kevin D Kelly,
  V. P. North American Sales
• Maik D Helmers,
  V.P. Central European Sales
• Guido J Neels,
  Director
• David N Gill,
  Director
• Duane M De Sisto,
  Director
• Martha Shadan,
  Director